My watch list
my.bionity.com  
Login  

Victoria
Australia

www.ludwig.edu.au/

Short description

LICR is an international non-profit organization committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for patient benefit. Since its establishment in 1971, the Institute has expended more than $1.5 billion on cancer research.

Watchlist

This is where you can add this research institute to your personal favourites

Additional Information

More about Ludwig Institute for Cancer Research
Contact
Ludwig Institute for Cancer Research (LICR)


  • News

    Pathway controlling cell growth revealed

    A Melbourne-based research team has discovered a genetic defect that can halt cell growth and force cells into a death-evading survival state. The finding has revealed an important mechanism controlling the growth of rapidly-dividing cells that may ultimately lead to the development of new ... more

    Nanosensors support skin cancer therapy

    Malignant melanoma is the most aggressive type of skin cancer. In more than 50 percent of affected patients a particular mutation plays an important role. As the life span of the patients carrying the mutation can be significantly extended by novel drugs, it is very important to identify th ... more

    iTeos Therapeutics launched to develop immunomodulators

    The Ludwig Institute for Cancer Research (LICR) announced the launch of a private biotechnology enterprise, iTeos Therapeutics SA, to develop a pre-clinical pipeline of immunomodulators to stimulate the immune system’s ability to attack cancer. Founded by LICR with the de Duve Institute at ... more

  • Research Institutes

    Ludwig Institute for Cancer Research (LICR)

    LICR is an international non-profit organization committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institu ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE